Genetics
- Genetics
DNA may determine if you’re an early bird or night owl
Morning people are more likely to have certain variations in their DNA, but less likely to have insomnia or sleep apnea.
- Genetics
DNA may determine if you’re an early bird or night owl
Morning people are more likely to have certain variations in their DNA, but less likely to have insomnia or sleep apnea.
- Genetics
U.K. first to approve gene editing of human embryos for research
The United Kingdom is the first government to approve gene editing in human embryos for research purposes.
- Microbes
Random changes in behavior speed bacteria evolution
Microbes can speed up evolution by changing phenotypes.
- Genetics
Readers question gene-drive engineered mosquitoes and their predators
Readers discuss the effects of gene-drive engineered mosquitoes and muse on their science bucket list.
- Science & Society
Powerful rhetoric can overlook important details
Our Editor in Chief discusses the potential hazards of broad generalizations, specifically when it comes to genetically modified foods and abundant energy.
- Genetics
GMOs haven’t delivered on their promises — or risks
Genetically modified foods have been studied extensively and are abundant on supermarket shelves, but they haven’t managed to end world hunger yet.
- Genetics
Mice can be male without Y chromosome
Researchers bypass the Y chromosome to make male mice.
- Genetics
Bubonic plague hung out in Europe
The plague bacterium Yersinia pestis may have lurked in a medieval European reservoir for at least 300 years, researchers from Germany suggest January 13 in PLOS ONE.
- Genetics
Bubonic plague hung around in Europe
DNA from plague victims suggests that a European reservoir of the plague bacterium Yersinia pestis could have fueled the medieval pandemic.
- Genetics
Drug candidate fails to improve symptoms of fragile X syndrome
A drug designed to treat fragile X syndrome has proven ineffective in clinical trials.
- Genetics
Drug candidate fails to improve symptoms of fragile X syndrome
A drug designed to treat fragile X syndrome has proven ineffective in clinical trials.
